Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 277

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis

Open access
Bidard, François-Clément, Michiels, Stefan, Riethdorf, Sabine, Mueller, Volkmar, Esserman, Laura J, Lucci, Anthony, Naume, Bjørn, Horiguchi, Jun, Gisbert-Criado, Rafael, Sleijfer, Stefan, Toi, Masakazu, Garcia-Saenz, Jose A, Hartkopf, Andreas, Generali, Daniele, Rothé, Françoise, Smerage, Jeffrey, Muinelo-Romay, Laura, Stebbing, Justin, Viens, Patrice, Magbanua, Mark Jesus M, Hall, Carolyn S, Engebraaten, Olav, Takata, Daisuke, Vidal-Martínez, José, Onstenk, Wendy, Fujisawa, Noriyoshi, Diaz-Rubio, Eduardo, Taran, Florin-Andrei, Cappelletti, Maria Rosa, Ignatiadis, Michail, Proudhon, Charlotte, Wolf, Denise M, Bauldry, Jessica B, Borgen, Elin, Nagaoka, Rin, Carañana, Vicente, Kraan, Jaco, Maestro, Marisa, Brucker, Sara Yvonne, Weber, Karsten, Reyal, Fabien, Amara, Dominic, Karhade, Mandar G, Mathiesen, Randi R, Tokiniwa, Hideaki, Llombart-Cussac, Antonio, Meddis, Alessandra, Blanche, Paul, d'Hollander, Koenraad, Cottu, Paul, Park, John W, Loibl, Sibylle, Latouche, Aurélien, Pierga, Jean-Yves, Pantel, Klaus · 2018 · JNCI: Journal of the National Cancer Institute

Abstract

Background: We conducted a meta-analysis in nonmetastatic breast cancer patients treated by neoadjuvant chemotherapy (NCT) to assess the clinical validity of circulating tumor cell (CTC) detection as a prognostic marker. Methods: We collected individual patient data from 21 studies in which CTC detection by CellSearch was performed in early breast cancer patients treated with NCT. The primary end point was overall survival, analyzed according to CTC detection, using Cox regression models stratified by study. Secondary end points included distant disease-free survival, locoregional relapse-free interval, and pathological complete response. All statistical tests were two-sided. Results: Data from patients were collected before NCT (n = 1574) and before surgery (n = 1200). CTC detection revealed one or more CTCs in 25.2% of patients before NCT; this was associated with tumor size (P < .001). The number of CTCs detected had a detrimental and decremental impact on overall survival (P < .001), distant disease-free survival (P < .001), and locoregional relapse-free interval (P < .001), but not on pathological complete response. Patients with one, two, three to four, and five or more CTCs before NCT displayed hazard ratios of death of 1.09 (95% confidence interval [CI] = 0.65 to 1.69), 2.63 (95% CI = 1.42 to 4.54), 3.83 (95% CI = 2.08 to 6.66), and 6.25 (95% CI = 4.34 to 9.09), respectively. In 861 patients with full data available, adding CTC detection before NCT increased the prognostic ability of multivariable prognostic models for overall survival (P < .001), distant disease-free survival (P < .001), and locoregional relapse-free interval (P = .008). Conclusions: CTC count is an independent and quantitative prognostic factor in early breast cancer patients treated by NCT. It complements current prognostic models based on tumor characteristics and response to therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/djy018

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 277

Metadata

Authors
Bidard, F.-C., Michiels, S., Riethdorf, S., Mueller, V., Esserman, L. J., Lucci, A., Naume, B., Horiguchi, J., Gisbert-Criado, R., Sleijfer, S., Toi, M., Garcia-Saenz, J. A., Hartkopf, A., Generali, D., Rothé, F., Smerage, J., Muinelo-Romay, L., Stebbing, J., Viens, P., Magbanua, M. J. M., Hall, C. S., Engebraaten, O., Takata, D., Vidal-Martínez, J., Onstenk, W., Fujisawa, N., Diaz-Rubio, E., Taran, F.-A., Cappelletti, M. R., Ignatiadis, M., Proudhon, C., Wolf, D. M., Bauldry, J. B., Borgen, E., Nagaoka, R., Carañana, V., Kraan, J., Maestro, M., Brucker, S. Y., Weber, K., Reyal, F., Amara, D., Karhade, M. G., Mathiesen, R. R., Tokiniwa, H., Llombart-Cussac, A., Meddis, A., Blanche, P., d'Hollander, K., Cottu, P., Park, J. W., Loibl, S., Latouche, A., Pierga, J.-Y., & Pantel, K.
Venue
JNCI: Journal of the National Cancer Institute
Published
2018-04-12
Volume
110
Issue
6
Pages
560-567
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2796752297
Cited by
277
References
19
FWCI
3.62
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. https://app.cochat.ai/papers/10.1093/jnci/djy018
The paper
Bidard, F.-C., Michiels, S., Riethdorf, S., Mueller, V., Esserman, L. J., Lucci, A., Naume, B., Horiguchi, J., Gisbert-Criado, R., Sleijfer, S., Toi, M., Garcia-Saenz, J. A., Hartkopf, A., Generali, D., Rothé, F., Smerage, J., Muinelo-Romay, L., Stebbing, J., Viens, P., . . . Pantel, K. (2018). Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djy018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.